Jiten Vora

5.8k total citations
148 papers, 4.2k citations indexed

About

Jiten Vora is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Jiten Vora has authored 148 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Endocrinology, Diabetes and Metabolism, 26 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Jiten Vora's work include Diabetes Treatment and Management (58 papers), Diabetes Management and Research (41 papers) and Metabolism, Diabetes, and Cancer (24 papers). Jiten Vora is often cited by papers focused on Diabetes Treatment and Management (58 papers), Diabetes Management and Research (41 papers) and Metabolism, Diabetes, and Cancer (24 papers). Jiten Vora collaborates with scholars based in United Kingdom, United States and Canada. Jiten Vora's co-authors include Simon Harding, Deborah Broadbent, Aftab Ahmad, William D. Fraser, David R. Owens, Naveed Younis, John R. Peters, Marc Evans, Michael J. Diver and Komal Imtiaz and has published in prestigious journals such as The Lancet, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Jiten Vora

144 papers receiving 4.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jiten Vora 2.1k 777 776 712 659 148 4.2k
Nicolai Balle Larsen 2.2k 1.1× 453 0.6× 376 0.5× 1.3k 1.8× 617 0.9× 32 4.7k
Kristian F. Hanssen 2.7k 1.3× 443 0.6× 557 0.7× 686 1.0× 1.2k 1.8× 143 5.5k
Su Chi Lim 1.1k 0.5× 410 0.5× 323 0.4× 1.3k 1.9× 570 0.9× 146 4.7k
Eugene Manley 5.3k 2.5× 423 0.5× 484 0.6× 1.4k 1.9× 1.3k 1.9× 13 7.2k
Honora H. McElroy 5.3k 2.5× 430 0.6× 484 0.6× 1.4k 1.9× 1.3k 1.9× 6 7.3k
E M Kohner 5.5k 2.6× 599 0.8× 645 0.8× 1.4k 2.0× 1.3k 2.0× 21 7.8k
Hans J. Arnqvist 3.2k 1.5× 272 0.4× 301 0.4× 1.2k 1.7× 1.6k 2.4× 167 5.7k
Susanna Morano 1.1k 0.5× 176 0.2× 144 0.2× 681 1.0× 490 0.7× 132 3.6k
Tavintharan Subramaniam 1.1k 0.5× 193 0.2× 170 0.2× 1.6k 2.3× 636 1.0× 174 4.7k
Yu‐Bae Ahn 1.4k 0.7× 178 0.2× 150 0.2× 468 0.7× 872 1.3× 115 2.9k

Countries citing papers authored by Jiten Vora

Since Specialization
Citations

This map shows the geographic impact of Jiten Vora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiten Vora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiten Vora more than expected).

Fields of papers citing papers by Jiten Vora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiten Vora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiten Vora. The network helps show where Jiten Vora may publish in the future.

Co-authorship network of co-authors of Jiten Vora

This figure shows the co-authorship network connecting the top 25 collaborators of Jiten Vora. A scholar is included among the top collaborators of Jiten Vora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiten Vora. Jiten Vora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fineman, Mark, Michael Horowitz, Jiten Vora, et al.. (2023). First‐in‐human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations. Diabetes Obesity and Metabolism. 25(9). 2447–2456. 9 indexed citations
2.
Hejjaji, Vittal, Juan José Gorgojo Martínez, Fengming Tang, et al.. (2022). Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study. Diabetes Obesity and Metabolism. 24(9). 1734–1740. 2 indexed citations
3.
Clegg, Lindsay E., Yankang Jing, Robert C. Penland, et al.. (2021). Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR‐TIMI 53 cardiovascular outcomes trials. Diabetes Obesity and Metabolism. 23(5). 1101–1110. 5 indexed citations
4.
Broadbent, Deborah, Christopher P. Cheyne, Marilyn James, et al.. (2020). Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT. Diabetologia. 64(1). 56–69. 22 indexed citations
5.
Idris, Iskandar, Jason Gordon, Carl Tilling, & Jiten Vora. (2014). A cost comparison of long-acting insulin analogs vs NPH insulin-based treatment in patients with type 2 diabetes using routinely collected primary care data from the UK. Journal of Medical Economics. 18(4). 273–282. 8 indexed citations
6.
Nnamoko, Nonso, et al.. (2013). Fuzzy Expert System for Type 2 Diabetes Mellitus (T2DM) Management Using Dual Inference Mechanism. Edge Hill University Research Information Repository (Edge Hill University). 5 indexed citations
7.
Evans, Marc, P.‐M. Schumm‐Draeger, Jiten Vora, & Allen B. King. (2011). A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations. Diabetes Obesity and Metabolism. 13(8). 677–684. 109 indexed citations
8.
Ross, Stuart A., Grzegorz Dzida, Jiten Vora, et al.. (2011). Impact of weight gain on outcomes in type 2 diabetes. Current Medical Research and Opinion. 27(7). 1431–1438. 73 indexed citations
9.
Miller, H., Paul W. Dyce, R. Grainger, et al.. (2009). Mechanisms of glucose intolerance in cystic fibrosis. Diabetic Medicine. 26(6). 582–588. 48 indexed citations
10.
Sodi, Ravinder, et al.. (2005). Testosterone replacement-induced hyperprolactinaemia: case report and review of the literature. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 42(2). 153–159. 16 indexed citations
11.
12.
Ahmad, Aftab, et al.. (2003). Gender variation in leptin circadian rhythm and pulsatility in adult growth hormone deficiency: effects of growth hormone replacement. Clinical Endocrinology. 58(4). 482–488. 8 indexed citations
13.
14.
Younis, Naveed, Robert A. Sells, A. D. DESMOND, et al.. (2002). Painful cutaneous lesions, renal failure and urgent parathyroidectomy.. PubMed. 15(3). 324–9. 13 indexed citations
15.
Ahmad, Aftab, et al.. (2002). Effects of GH replacement on 24‐h ambulatory blood pressure and its circadian rhythm in adult GH deficiency. Clinical Endocrinology. 56(4). 431–437. 16 indexed citations
16.
Younis, N., Patricia Burnham, Ashish Patwala, PJ Weston, & Jiten Vora. (2001). Beta blocker prescribing differences in patients with and without diabetes following a first myocardial infarction. Diabetic Medicine. 18(2). 159–161. 11 indexed citations
17.
Tesfaye, Solomon, et al.. (1998). Pregnant, vomiting, and going blind. The Lancet. 352(9140). 1594–1594. 19 indexed citations
18.
Shannon, A. G., et al.. (1995). Radioactive labelled insulin kinetics. International Journal of Mathematical Education in Science and Technology. 26(3). 329–335. 2 indexed citations
19.
Vora, Jiten, et al.. (1988). Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.. BMJ. 297(6658). 1236–1239. 29 indexed citations
20.
Ryder, Robert E. J., et al.. (1985). Possible new method to improve detection of diabetic retinopathy: Polaroid non-mydriatic retinal photography.. BMJ. 291(6504). 1256–1257. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolai Balle Larsen Breakdown of academic impact, for papers by Kristian F. Hanssen Breakdown of academic impact, for papers by Su Chi Lim Breakdown of academic impact, for papers by Eugene Manley Breakdown of academic impact, for papers by Honora H. McElroy Breakdown of academic impact, for papers by E M Kohner Breakdown of academic impact, for papers by Hans J. Arnqvist Breakdown of academic impact, for papers by Susanna Morano Breakdown of academic impact, for papers by Tavintharan Subramaniam Breakdown of academic impact, for papers by Yu‐Bae Ahn
Rankless by CCL
2026